Nephrotoxicities [version 1; referees: 2 approved]

Nephrotoxicities [version 1; referees: 2 approved]

Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying...

Full description

Bibliographic Details
Main Author: Stuart L. Goldstein
Format: Article
Language:English
Published: F1000 Research Ltd 2017-01-01
Series:F1000Research
Subjects:
Acute Renal Failure
Epidemiology
Immunological Biomarkers
Renal & Gastrointestinal Problems in Critical Care
Toxicology
Online Access:https://f1000research.com/articles/6-55/v1
id doaj-1fa7908bc5914978be87627055d4b3da
record_format Article
spelling doaj-1fa7908bc5914978be87627055d4b3da2020-11-25T03:31:46ZengF1000 Research LtdF1000Research2046-14022017-01-01610.12688/f1000research.10192.110979Nephrotoxicities [version 1; referees: 2 approved]Stuart L. Goldstein0Center for Acute Care Nephrology, Cincinnati Children’s Hospital Medical Center, Cininnati, OH, USANephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying illness, unnecessary nephrotoxic medication exposure can be viewed as a potentially modifiable adverse safety event if AKI can be prevented. The advancements in electronic health record development, standardization of AKI definitions, and the ability to identify AKI risk and development in near real time provide opportunities to reduce harm from nephrotoxicity.https://f1000research.com/articles/6-55/v1Acute Renal FailureEpidemiologyImmunological BiomarkersRenal & Gastrointestinal Problems in Critical CareToxicology
collection DOAJ
language English
format Article
sources DOAJ
author Stuart L. Goldstein
spellingShingle Stuart L. Goldstein
Nephrotoxicities [version 1; referees: 2 approved]
F1000Research
Acute Renal Failure
Epidemiology
Immunological Biomarkers
Renal & Gastrointestinal Problems in Critical Care
Toxicology
author_facet Stuart L. Goldstein
author_sort Stuart L. Goldstein
title Nephrotoxicities [version 1; referees: 2 approved]
title_short Nephrotoxicities [version 1; referees: 2 approved]
title_full Nephrotoxicities [version 1; referees: 2 approved]
title_fullStr Nephrotoxicities [version 1; referees: 2 approved]
title_full_unstemmed Nephrotoxicities [version 1; referees: 2 approved]
title_sort nephrotoxicities [version 1; referees: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2017-01-01
description Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying illness, unnecessary nephrotoxic medication exposure can be viewed as a potentially modifiable adverse safety event if AKI can be prevented. The advancements in electronic health record development, standardization of AKI definitions, and the ability to identify AKI risk and development in near real time provide opportunities to reduce harm from nephrotoxicity.
topic Acute Renal Failure
Epidemiology
Immunological Biomarkers
Renal & Gastrointestinal Problems in Critical Care
Toxicology
url https://f1000research.com/articles/6-55/v1
work_keys_str_mv AT stuartlgoldstein nephrotoxicitiesversion1referees2approved
_version_ 1724571853149700096

Similar Items